|Title:||Benzimidazole compound crystal|
|Abstract:|| A novel crystal of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-- 1H-benzimidazole or a salt thereof of the present invention is useful for an excellent antiulcer agent.|
|Inventor(s):|| Fujishima; Akira (Hyogo, JP), Aoki; Isao (Hyogo, JP), Kamiyama; Keiji (Osaka, JP) |
|Assignee:|| Takeda Pharmaceutical Company Limited (Osaka, JP) |
|Filing Date:||Feb 26, 2009|
|Claims:||1. An amorphous compound of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-- 1H-benzimidazole or a salt thereof. |
2. A pharmaceutical composition comprising the amorphous compound according to claim 1 and a pharmaceutically acceptable excipient, carrier or diluent.
3. A pharmaceutical composition according to claim 2, wherein the pharmaceutical composition includes an effective amount of the amorphous compound to treat or prevent digestive ulcer.
4. A method for treating or preventing digestive ulcer, which comprises administering to a mammal in need thereof an effective amount of the amorphous compound of claim 1.